ecrin-mdr-crcClinical2021EGFRI Induced Acneiform LesionsEgfri Induced Acneiform LesionsInterventionalhttps://newmdr.ecrin.org/Study/2367764United StatesIsrael4EGFRI, Acneiform, Acneiform lesions, Acneiform rash, EGFRI induced skin toxicitiesLUT014ECRIN MDRRecruitingfalseLUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRCThe study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorectal cancer (mCRC) patients who developed Grade 2 or non-infected Grade 3 EGFRI induced acneiform lesions2021-04-152367764NCT04759664